These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38478483)

  • 1. The trajectories of CD4 T lymphocytes over time in patients who have defaulted on treatment for tuberculosis in a cohort of people living with HIV, Recife/PE.
    Cunha R; Filho DBM; M Albuquerque MFP; Lacerda HR; Diniz GTN; Montarroyos UR; Rodrigues LC; Vilela Moura LCR; Ximenes RAA
    PLoS One; 2024; 19(3):e0299244. PubMed ID: 38478483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of people living with HIV who defaulted from tuberculosis treatment in a cohort, Recife, Brazil.
    Cunha R; Maruza M; Montarroyos UR; Coimbra I; de B Miranda-Filho D; Albuquerque MF; Lacerda HR; Ximenes R
    BMC Infect Dis; 2017 Feb; 17(1):137. PubMed ID: 28187753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empirical treatment for TB in HIV: lessons from a cohort study of people living with HIV treated in Recife, Brazil.
    Albuquerque Mde F; Coimbra I; Batista Jd; Maruza M; Ximenes RA; Lacerda HR; Miranda-Filho DB; Santos ML; Rodrigues LC
    BMC Public Health; 2014 Mar; 14():289. PubMed ID: 24679187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection.
    Gupta RK; Brown AE; Zenner D; Rice B; Yin Z; Thomas HL; Pozniak A; Abubakar I; Delpech V; Lipman M
    AIDS; 2015 Jul; 29(11):1363-8. PubMed ID: 26091298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
    Bwire R; Nagelkerke NJ; Borgdorff MW
    Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of tuberculosis and antiretroviral treatment on CD4+ cell count response in HIV-positive tuberculosis patients in Mozambique.
    Brouwer M; Gudo PS; Simbe CM; Perdigão P; van Leth F
    BMC Public Health; 2012 Aug; 12():670. PubMed ID: 22900904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting.
    Hermans SM; Manabe YC; Kiragga AN; Hoepelman AI; Lange JM; van Leth F
    Antivir Ther; 2013; 18(4):615-22. PubMed ID: 23423604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for default from tuberculosis treatment in HIV-infected individuals in the state of Pernambuco, Brazil: a prospective cohort study.
    Maruza M; Albuquerque MF; Coimbra I; Moura LV; Montarroyos UR; Miranda Filho DB; Lacerda HR; Rodrigues LC; Ximenes RA
    BMC Infect Dis; 2011 Dec; 11():351. PubMed ID: 22176628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Latent M. tuberculosis Infection Treatment on Time to CD4/CD8 Recovery in Acute, Recent, and Chronic HIV Infection.
    Grinsztejn E; Cardoso SW; Velasque L; Hoagland B; Dos Santos DG; Coutinho C; Cruz Silva SDC; Nazer SC; Ferreira ACG; Castilho J; Grinsztejn B; Veloso VG
    J Acquir Immune Defic Syndr; 2023 Dec; 94(4):355-363. PubMed ID: 37595204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active tuberculosis is associated with worse clinical outcomes in HIV-infected African patients on antiretroviral therapy.
    Siika AM; Yiannoutsos CT; Wools-Kaloustian KK; Musick BS; Mwangi AW; Diero LO; Kimaiyo SN; Tierney WM; Carter JE
    PLoS One; 2013; 8(1):e53022. PubMed ID: 23301015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration and task shifting for TB/HIV care and treatment in highly resource-scarce settings: one size may not fit all.
    Van Rie A; Patel MR; Nana M; Vanden Driessche K; Tabala M; Yotebieng M; Behets F
    J Acquir Immune Defic Syndr; 2014 Mar; 65(3):e110-7. PubMed ID: 24091692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.
    Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
    PLoS One; 2012; 7(3):e34156. PubMed ID: 22479548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Simultaneous treatment of HIV and tuberculosis is possible and necessary].
    von der Maase S; Gerstoft J; Wejse C
    Ugeskr Laeger; 2014 Feb; 176(6A):V03130163. PubMed ID: 25347439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and predictors of reoccurrence of opportunistic infection among adult HIV/AIDS patients attending ART clinic at public health facilities in Arba Minch town, southern Ethiopia: A retrospective cohort study.
    Dembelu M; Kote M; Gilano G; Mohammed T
    PLoS One; 2021; 16(12):e0261454. PubMed ID: 34972122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of antiretroviral and tuberculosis therapies on CD4
    Chiacchio T; Petruccioli E; Vanini V; Cuzzi G; La Manna MP; Orlando V; Pinnetti C; Sampaolesi A; Antinori A; Caccamo N; Goletti D
    Immunol Lett; 2018 Jun; 198():33-43. PubMed ID: 29635002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies.
    Fenner L; Atkinson A; Boulle A; Fox MP; Prozesky H; Zürcher K; Ballif M; Furrer H; Zwahlen M; Davies MA; Egger M;
    J Int AIDS Soc; 2017 Jun; 20(1):21327. PubMed ID: 28691438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy improves survival among TB-HIV co-infected patients who have CD4+ T-cell count above 350cells/mm
    Mutembo S; Mutanga JN; Musokotwane K; Alisheke L; Whalen CC
    BMC Infect Dis; 2016 Oct; 16(1):572. PubMed ID: 27751168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Clinical Algorithm to Identify HIV Patients at High Risk for Incident Active Tuberculosis: A Prospective 5-Year Cohort Study.
    Lee SS; Lin HH; Tsai HC; Su IJ; Yang CH; Sun HY; Hung CC; Sy CL; Wu KS; Chen JK; Chen YS; Fang CT
    PLoS One; 2015; 10(8):e0135801. PubMed ID: 26280669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of antiretroviral therapy with tuberculosis treatment.
    Abdool Karim SS; Naidoo K; Grobler A; Padayatchi N; Baxter C; Gray AL; Gengiah T; Gengiah S; Naidoo A; Jithoo N; Nair G; El-Sadr WM; Friedland G; Abdool Karim Q
    N Engl J Med; 2011 Oct; 365(16):1492-501. PubMed ID: 22010915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of incident tuberculosis on immunological response of HIV patients on highly active anti-retroviral therapy at the university of Gondar hospital, northwest Ethiopia: a retrospective follow-up study.
    Assefa A; Gelaw B; Getnet G; Yitayew G
    BMC Infect Dis; 2014 Aug; 14():468. PubMed ID: 25164855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.